GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Stemtech Corp (OTCPK:STEK) » Definitions » 3-Year ROIIC %

STEK (Stemtech) 3-Year ROIIC % : -161.63% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Stemtech 3-Year ROIIC %?

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Stemtech's 3-Year ROIIC % for the quarter that ended in Dec. 2023 was -161.63%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Stemtech's 3-Year ROIIC % or its related term are showing as below:

STEK's 3-Year ROIIC % is ranked worse than
93.79% of 998 companies
in the Drug Manufacturers industry
Industry Median: 0.915 vs STEK: -161.63

Stemtech 3-Year ROIIC % Historical Data

The historical data trend for Stemtech's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stemtech 3-Year ROIIC % Chart

Stemtech Annual Data
Trend Dec20 Dec21 Dec22 Dec23
3-Year ROIIC %
- - - -161.63

Stemtech Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -161.63 - - -

Competitive Comparison of Stemtech's 3-Year ROIIC %

For the Drug Manufacturers - Specialty & Generic subindustry, Stemtech's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stemtech's 3-Year ROIIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Stemtech's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Stemtech's 3-Year ROIIC % falls into.



Stemtech 3-Year ROIIC % Calculation

Stemtech's 3-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( -4.225 (Dec. 2023) - -1.432 (Dec. 2020) )/( 7.035 (Dec. 2023) - 5.307 (Dec. 2020) )
=-2.793/1.728
=-161.63%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Stemtech  (OTCPK:STEK) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Stemtech 3-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Stemtech's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Stemtech Business Description

Traded in Other Exchanges
N/A
Address
4851 Tamiami Trail North, Suite 200, Naples, FL, USA, 34103
Stemtech Corp is a nutraceutical company. Its products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood and migrate them into tissues, where perform their daily function of renewal for optimal health. It markets its products under the following brands: RCM System, stemrelease3, Stemflo MigraStem, OraStem (Oral Health Care), and D-Fuze. Geographically, it derives a majority of its revenue from the Americas.
Executives
Charles Stuart Arnold director 520 BRICKELL KEY DR #1607, MIAMI FL 33131
Mindshare Holdings, Inc. 10 percent owner 419 BOSTWICK LANE, GAITHERSBURG MD 20878
Darryl V Green director 300 SIXTH AVENUE, PITTSBURGH PA 15222
John William Meyer director 10370 USA TODAY WAY, MIRAMAR FL 33025
Benjamin Nathaniel Kaplan director 13005 CORONOADO LANE, NORTH MIAMI FL 33181